Lanabecestat
5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
5
Ongoing
0
Recruiting
0
Completed
2
Sites
495
Countries
23
Endpoints
95
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 95 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 38 of 95 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
8
6
6
6
4
4
4
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
5 of 5
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| DAYBREAK-ALZA Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia | Lanabecestat Alzheimer’s disease | mild AD dementia | Ph 3 | Terminated | 262 | Sep 2018 | 2 | results |
| AMARANTHAn Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease | Lanabecestat Alzheimer’s disease | MCI due to AD | Ph 2/3 | Terminated | 254 | Oct 2018 | 4 | results |
| NCT02972658A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia | Lanabecestat Alzheimer’s disease | Age ≥55 | Ph 3 | Terminated | 133 | Oct 2018 | - | results |
| AZD3293TQTAZD3293 Thorough QT Study in Healthy Male Volunteers | Lanabecestat Alzheimer’s disease | Age 18-55 | Ph 1 | Completed | 1 | May 2014 | - | |
| NCT01795339A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients | Lanabecestat Alzheimer’s disease | Alzheimer's disease | Ph 1 | Completed | 1 | Mar 2014 | 1 |
Showing 1-5 of 5 trials